Importer of Controlled Substances Application: Cardinal Health, 21764 [2021-08537]
Download as PDF
<![CDATA[
21764
Federal Register / Vol. 86, No. 77 / Friday, April 23, 2021 / Notices
that an industry in the United States is
materially injured by reason of imports
of seamless carbon and alloy steel
standard, line, and pressure pipe from
Czechia, provided for in subheadings
7304.19.10, 7304.19.50, 7304.31.60,
7304.39.00, 7304.51.50, 7304.59.60, and
7304.59.80 of the Harmonized Tariff
Schedule of the United States, that have
been found by the U.S. Department of
Commerce (‘‘Commerce’’) to be sold in
the United States at less than fair value
(‘‘LTFV’’).2
Background
The Commission instituted this
investigation effective July 8, 2020,
following receipt of petitions filed with
the Commission and Commerce by
Vallourec Star, LP, Houston, Texas. The
Commission scheduled the final phase
of the investigation following
notification of a preliminary
determination by Commerce that
imports of seamless carbon and alloy
steel standard, line, and pressure pipe
from Czechia were being sold at LTFV
within the meaning of section 733(b) of
the Act (19 U.S.C. 1673b(b)). Notice of
the scheduling of the final phase of the
Commission’s investigation and of a
public hearing to be held in connection
therewith was given by posting copies
of the notice in the Office of the
Secretary, U.S. International Trade
Commission, Washington, DC, and by
publishing the notice in the Federal
Register of December 31, 2021 (85 FR
86946). In light of the restrictions on
access to the Commission building due
to the COVID–19 pandemic, the
Commission conducted its hearing
through written testimony and video
conference on March 4, 2021. All
persons who requested the opportunity
were permitted to participate.
khammond on DSKJM1Z7X2PROD with NOTICES
The Commission made this
determination pursuant to § 735(b) of
the Act (19 U.S.C. 1673d(b)). It
completed and filed its determination in
this investigation on April 19, 2021. The
views of the Commission are contained
in USITC Publication 5183 (April 2021),
entitled Seamless Carbon and Alloy
Steel Standard, Line, and Pressure Pipe
from Czechia: Investigation No. 731–
TA–1529 (Final).
[FR Doc. 2021–08442 Filed 4–22–21; 8:45 am]
BILLING CODE 7020–02–P
FR 12909 (March 5, 2021).
VerDate Sep<11>2014
18:15 Apr 22, 2021
Drug Enforcement Administration
[Docket No. DEA–820]
Jkt 253001
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–08537 Filed 4–22–21; 8:45 am]
Importer of Controlled Substances
Application: Cardinal Health
BILLING CODE P
Drug Enforcement
Administration, Department of Justice.
ACTION: Notice of application.
DEPARTMENT OF JUSTICE
AGENCY:
Cardinal Health has applied
to be registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplemental Information
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 24, 2021. Such persons
may also file a written request for a
hearing on the application on or before
May 24, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on February 15, 2021
Cardinal Health, 15 Ingram Boulevard,
La Vergne, Tennessee 37086–3630,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
DATES:
Drug
code
Controlled substance
Nabilone .......................
By order of the Commission.
Issued: April 19, 2021.
Lisa Barton,
Secretary to the Commission.
2 86
DEPARTMENT OF JUSTICE
I
7379
Schedule
I II
The company plans to import finished
dosage unit products containing
Nabilone for distribution. No other
activity for this drug code is authorized
for this registration.
Approval of permit applications will
occur only when the registrant’s
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
Drug Enforcement Administration
[Docket No. DEA–821]
Importer of Controlled Substances
Application: Lipomed
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice of application.
Lipomed has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplemental Information
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 24, 2021. Such persons
may also file a written request for a
hearing on the application on or before
May 24, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on February 26, 2021, 150
Cambridgepark Drive, Suite 705,
Cambridge, Massachusetts 02140,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
E:\FR\FM\23APN1.SGM
23APN1
]]>Agencies
[Federal Register Volume 86, Number 77 (Friday, April 23, 2021)]
[Notices]
[Page 21764]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08537]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-820]
Importer of Controlled Substances Application: Cardinal Health
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Cardinal Health has applied to be registered as an importer of
basic class(es) of controlled substance(s). Refer to Supplemental
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before May 24, 2021.
Such persons may also file a written request for a hearing on the
application on or before May 24, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on February 15, 2021 Cardinal Health, 15 Ingram
Boulevard, La Vergne, Tennessee 37086-3630, applied to be registered as
an importer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Nabilone............................... 7379 II
------------------------------------------------------------------------
The company plans to import finished dosage unit products
containing Nabilone for distribution. No other activity for this drug
code is authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2).
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-08537 Filed 4-22-21; 8:45 am]
BILLING CODE P
